In today’s briefing:
- Tencent Investee Selldown – The US$120bn Global Overhang
- Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer
- Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile
- Jinke Smart’s VGO of HK$12.00 from Boyu Capital
- Tencent Increases Its Investment in Medical and Healthcare
- Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance
- FTSE China A50 Index Rebalance Preview: Tight Margins
- Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market
- Morning Views Asia: Road King Infrastructure
Tencent Investee Selldown – The US$120bn Global Overhang
- Multiple new agencies have been reporting that Tencent (700 HK) plans to trim its investment portfolio over the remainder of the year.
- The reports have been coming in since the second half of the year and the company has been duly denying these rumors.
- In this note, we look at Tencent’s shareholding in various companies to try and gauge which ones it could sell out of and how.
Jinke Smart (9666 HK)’s Low-Balled But Virtually Unconditional Offer
- PRC-Incorporated property management play Jinke Smart Services (9666 HK) has announced a voluntary cash offer at HK$12/share, a 33.04% premium to last close.
- The Offeror (Boyu) and concert parties collectively hold more than 50%. The Offer is contingent on regulatory approvals and 7.71% of shares out tendering. The tendering condition can be waived.
- The Offer appears geared to bring Boyu’s stake in line with Jinke Property Group (000656 CH)‘s.
Swire B Vs A – Surprising on Regs, Surprising on Risk; Short-Tm Displacement Now in 99th Percentile
- The Swire buyback has been impressive. In 27 trading days they have bought back 26.8% of teh HK$4bn promised. In that period, participation has been aggressive.
- Swire has bought back As at a pace of 52% of pre-buyback one-year ADV. For Bs, it has been 105%. But Bs have dramatically underperformed As on “HK Re-opening” trades.
- Historically, when B/A gets more than 6% from 3mo Avg VWAP Ratio, there is statistically significant reversion. We are now at 6.8%. I’d buy B vs A.
Jinke Smart’s VGO of HK$12.00 from Boyu Capital
- Jinke Smart Services (9666 HK) announced a voluntary conditional general offer from Boyu Capital at HK$12.00 per share, a 33.0% premium to the undisturbed price.
- The offer is conditional on 7.71% valid acceptances (such that Boyu represents 30.40% of outstanding shares) and anti-trust approval. The conditions can be waived.
- The offer is designed to flush out minorities unwilling to wait for the industry headwinds to dissipate. A low threshold suggests that the offer will be declared unconditional.
Tencent Increases Its Investment in Medical and Healthcare
- Tencent known to outspend its peers on strategic investments, has made only around 80 investments and acquisitions so far this year compared to more than 200 deals done in 2021.
- Tencent’s vast investment portfolio has attracted regulatory scrutiny and it’s the market’s belief that Tencent was asked to divest some of its stake in other leading tech players in China.
- However, over the last few months, Tencent has been increasingly investing on companies operating in the medical field.
Vipshop: Rebound in Chinese Apparel Sales Should Trump Conservative Management Guidance
- Following a contraction in Chinese apparel sales since 3Q21, and similar negative GMV and product revenue growth for Vipshop, we have witnessed a recovery to growth since June.
- Current sell-side forecasts are, however, still for a -10.8%y/y contraction in product revenue for Vipshop in 3Q22f, followed by a -4.4% contraction in 4Q22f which seems overly pessimistic.
- Given the conservative nature of near-term top-line growth expectation, and management guidance, the probability for positive earnings surprise seems high.
FTSE China A50 Index Rebalance Preview: Tight Margins
- Poly Real Estate Group Co., Ltd (600048 CH) sits at the edge of the inclusion zone for the FTSE China A50 Index (XIN9I INDEX) December rebalance.
- That inclusion could result in the deletion of any one of four stocks since they are all clustered within 0.7% of each other on full market cap.
- There are a few other stocks that are close to inclusion zone and a 5-10% rally in these stocks could result in more changes to the index in December.
Medlive Technology (2192.HK) 22H1- The Growth Logic/Business Model Is More Scrutinized by the Market
- The improvement of Medlive’s profitability in 22H1 seems more related to the large decreased income tax expense rather than any obvious improvement of main business or any other logic.
- The single main business structure and insufficient core competitiveness add uncertainty to the Company’s long-term prospects, which makes it difficult to significantly improve the valuation.
- Medlive is under double pressure of “squeezing bubble” in healthcare industry and “the fading of traffic dividend” in Internet industry.Its growth logic/business model will be more scrutinized by the market.
Morning Views Asia: Road King Infrastructure
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars